跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cataflam - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Cataflam
Approved
STANDARD
Cataflam
Novartis Saglik, Gida Ve Tarim Urunleri San, Ve Tic. A.S.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
375cbb1d5ec0e787
Company
Novartis Saglik, Gida Ve Tarim Urunleri San, Ve Tic. A.S.
Type
Standard
Approval Details
Approval Id
375cbb1d5ec0e787
Drug Approval Philippines Name
Cataflam
Product Name
Cataflam
Registration Number
DRP-7687
Brand Name
Cataflam
Generic Name
Diclofenac Potassium
Dosage Form
Sugar-Coated Tablet
Dosage Strength
50mg
Manufacturer
Novartis Saglik, Gida Ve Tarim Urunleri San, Ve Tic. A.S.
Importer
Novartis Healthcare Philippines, Inc.
Distributor
Novartis Healthcare Philippines, Inc.
Issuance Date
27 February 2024
Expiry Date
01 February 2029
Pharmacologic Category
Non-Steroidal Anti-inflammatory Drug (NSAID)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
375cbb1d5ec0e787
Type
Standard
Back to Philippines FDA Approvals